SE448145B - MINERAL WATER WITH PHYSIOLOGICALLY OPTIMIZED CATION COMPOSITION - Google Patents
MINERAL WATER WITH PHYSIOLOGICALLY OPTIMIZED CATION COMPOSITIONInfo
- Publication number
- SE448145B SE448145B SE8403228A SE8403228A SE448145B SE 448145 B SE448145 B SE 448145B SE 8403228 A SE8403228 A SE 8403228A SE 8403228 A SE8403228 A SE 8403228A SE 448145 B SE448145 B SE 448145B
- Authority
- SE
- Sweden
- Prior art keywords
- potassium
- mmol
- magnesium
- liter
- mineral water
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/40—Table salts; Dietetic salt substitutes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Mycology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Seasonings (AREA)
- Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Confectionery (AREA)
- Dairy Products (AREA)
Abstract
Description
448 145 åtgärder som spannmål och andra näringsämnen utsätts för (Meanely 1976). Under de senaste åren har den medicinska litteraturen beskrivit talrika störningar till följd av en disproportionerlig elektrolytsammansättning i födan. Är dessa störningar långvariga, leder de till patologiska förändringar i flera av organismens funktioner. Hypertoni och degenerativa kärl- och hjärtsjukdomar har i detta sam- band varit föremål för ett centralt intresse (Karppanen -78; Masironi -69; Meanely -76; Schroeder -74; WHO -73)t Trots den alarmerande situationen har tills vidare inga åtgärder vidtagits inom den normala nutritionen för opti- mering av tillgången på elektrolyter. 448 145 measures to which cereals and other nutrients are exposed (Meanely 1976). In recent years, the medical literature has described numerous disorders due to a disproportionate electrolyte composition in the diet. If these disorders are long-lasting, they lead to pathological changes in several of the organism's functions. Hypertension and degenerative vascular and cardiovascular diseases have been of central interest in this connection (Karppanen -78; Masironi -69; Meanely -76; Schroeder -74; WHO -73) t Despite the alarming situation, no measures have been taken so far. taken within the normal nutrition for optimizing the supply of electrolytes.
Från terapin av hjärtsjukdomar emanerar några begränsade försök att ersätta en del av saltbehovet i dieten, vanligast med kalium- eller ammoníumhaltiga substituter. Likalêdes har kaliumtabletter använts för att balansera ett natrium- överskott, som uppstått till följd av vissa läkemedel, bl a tiazider, som används i hypertoniterapin. Karakte- ristiskt för de använda metoderna är likväl att de är in- riktade på sjukdomstillstånd och endast på en kompensering av överskottet av natriumkatjoner utan att fästa någon uppmärksamhet på proportionerna av de övriga på situa- tionen dynamiskt inverkande katjonerna. Det nuvarande tänkesättet tar sålunda inte i beaktande betydelsen av en disproportionerlig tillgång på elektrolyter som orsak till svåra hälsovàdliga störningar, och de nuvarande me- toderna erbjuder ingen väsentlig möjlighet till eliminering av de rådande disproportionerna.From the therapy of heart disease emanates some limited attempts to replace some of the salt requirement in the diet, most often with potassium- or ammonium-containing substitutes. Likewise, potassium tablets have been used to balance an excess of sodium, which has arisen as a result of certain drugs, including thiazides, used in hypertension therapy. Characteristic of the methods used, however, is that they focus on disease states and only on compensating for the excess sodium cations without paying any attention to the proportions of the other cations dynamically influencing the situation. Thus, the current way of thinking does not take into account the importance of a disproportionate supply of electrolytes as a cause of severe health hazards, and the current methods offer no significant possibility of eliminating the prevailing disproportions.
Som bekant kan biokemiska livsfenomina endast ske i vissa vattenhaltiga elektrolytlösningar. I organismen upprätt- hålls dessa lösningar inom exakta gränser av ett centralt styrt vätske- och elektrolytsystem. De tre strukturella huvuddelarna i systemet är blodplasman, den inter- FST: 448 145 stitiella vätskan och intracellulära vätskan. Till grund för upprätthàllandet av den materiella balansen ligger ett kontinuerligt kompletterande flöde av vatten och elektrolyter, som från tarmarna strömmar genom systemet och avgår huvudsakligen genom njurarna. Upprätthállandet av skarpt avvikande katjon- och anjonhalter i cellorganen, den intracellulära vätskan och extracellulärutrymmet förut- sätter en aktiv regleringsverksamhet och en aktuell och genomsnittlig komplettering av de olika komponenterna' inom måttliga gränser. Om tillgången pà en eller flera katjoner under- eller överskrider de optimala gränserna, utsätts elektrolytsystemets regelsystem för en belastning, som direkt eller indirekt leder till förändringar och störningar inom systemet och övriga med dess funktion sammankopplade organiska system.As is well known, biochemical life phenomena can only occur in certain aqueous electrolyte solutions. In the organism, these solutions are maintained within precise limits by a centrally controlled fluid and electrolyte system. The three main structural parts of the system are the blood plasma, the intercellular fluid and the intracellular fluid. The basis for maintaining the material balance is a continuous complementary flow of water and electrolytes, which flow from the intestines through the system and leave mainly through the kidneys. The maintenance of sharply deviating cation and anion levels in the cell organs, the intracellular fluid and the extracellular space presupposes an active regulatory activity and a current and average supplementation of the various components' within moderate limits. If the supply of one or more cations falls below or exceeds the optimum limits, the control system of the electrolyte system is exposed to a load which directly or indirectly leads to changes and disturbances within the system and other organic systems connected to its function.
En av de viktigaste disproportionerna i den nuvarande nutritionen är den alltför rikliga tillgången på natrium, som framgår vid jämförelse av följande för vuxna rekommen- derade optimimängder natrium 10 - 60 mmol/dygn kalium 50 - 100 mmol/dygn magnesium 12 - 40 mmol/dygn kalcium 20 - 35 mmol/dygn med de mängder som invånarna i ett industrialiserat land har befunnits intaga i genomsnitt, d v s natrium 230 mmol/dygn, max 460 mmol/dygn kalium 60 mmol/dygn, min 10 mmol/dygn magnesium 15 mmol/dygn, min 2 mmol/dygn kalcium 60 mmol/dygn, max 210 mmol/dygn.One of the most important disproportions in the current nutrition is the excessive supply of sodium, which is evident when comparing the following recommended amounts of sodium for adults 10 - 60 mmol / day potassium 50 - 100 mmol / day magnesium 12 - 40 mmol / day calcium 20 - 35 mmol / day with the amounts that the inhabitants of an industrialized country have been found to consume on average, ie sodium 230 mmol / day, max 460 mmol / day potassium 60 mmol / day, min 10 mmol / day magnesium 15 mmol / day , min 2 mmol / day calcium 60 mmol / day, max 210 mmol / day.
(Karppanen -78, Meanely -76).(Karppanen -78, Meanely -76).
En av de centrala mekanismerna i natriumöverskottet grundar sig på förmågan hos natrium att öka avsöndringen av kalium i njurkanalerna, vilket åter leder till en kaliumförlust 448 145 i organismen. Då tillgången på kalium, såsom även framgår av tabellen, ofta är otillräcklig, är resultatet ofta en ökad disproportion i detta fysiologiskt viktiga jonpar.One of the central mechanisms of excess sodium is based on the ability of sodium to increase the excretion of potassium in the renal ducts, which in turn leads to a loss of potassium 448 145 in the organism. As the availability of potassium, as also shown in the table, is often insufficient, the result is often an increased disproportion in this physiologically important ion pair.
I omfattande undersökningar, som täckt flera länder, har hypertonifrekvensen visat sig korrelera kraftigt med det disproportionerliga bruket av natrium och kalium. Normalt borde födan innehålla natrium och kalium i ett optimalt molförhållande av Na:K = 1:1.In extensive studies, which covered several countries, the frequency of hypertension has been shown to correlate strongly with the disproportionate use of sodium and potassium. Normally the food should contain sodium and potassium in an optimal molar ratio of Na: K = 1: 1.
Haltproportionerna av kalcium och magnesium är av en central betydelse för ett flertal av hjärtats och nerv- systemets elektrofysiologiska och enzymatiska reaktioner.The content proportions of calcium and magnesium are of central importance for a number of the electrophysiological and enzymatic reactions of the heart and nervous system.
Som optimalt förhållande för deras molhalter i födan har beräknats: Ca:Mg = 1:1 - 2:1. Magnesium har vidare visat sig ha en avgörande, till utnyttjandet av kalium bidragande verkan. Även om den dagliga födan skulle inne- hålla kalium t o m i rikliga mängder, är organismen inte i .stånd att utnyttja det, utan kaliumet avsöndras snabbt under rådande brist på magnesium. Den intracellulära elektro- lytjämvikten förutsätter ett visst molförhàllande i födan mellan magnesium och kalium, som optimalt är Mg:K = 1:4.The optimal ratio for their molar contents in the diet has been calculated: Ca: Mg = 1: 1 - 2: 1. Magnesium has also been shown to have a decisive effect on the utilization of potassium. Even if the daily diet were to contain potassium even in copious amounts, the organism is not able to utilize it, but the potassium is rapidly excreted during the prevailing lack of magnesium. The intracellular electrolyte equilibrium presupposes a certain molar ratio in the diet between magnesium and potassium, which is optimally Mg: K = 1: 4.
Det har visat sig, att frekvensen av vissa hjärtsjuk- domar kraftigt korrelerar med en brist på kalium, speciellt då även tillgången på magnesium är otillräcklig (Karppanen 1978). Ifall födan innehåller kalcium i riklig mängd och magnesium i ringa mängd, minskar den rikliga kalcium- mängden väsentligt absorptionen av magnesium. Detta inne- bär, att vid en minskande tillgång på magnesium försvåras även det biologiska utnyttjandet av kalium. Optimalt borde födan innehålla kalcium och magnesium i ett molför- hållande av Ca:Mg = 1:1 - 2:1.It has been shown that the frequency of certain heart diseases strongly correlates with a lack of potassium, especially when the supply of magnesium is also insufficient (Karppanen 1978). If the food contains a large amount of calcium and a small amount of magnesium, the large amount of calcium significantly reduces the absorption of magnesium. This means that with a declining supply of magnesium, the biological utilization of potassium is also made more difficult. Optimally, the food should contain calcium and magnesium in a molar ratio of Ca: Mg = 1: 1 - 2: 1.
Sålunda har man tillgång till övertygande vetenskapligt bevismaterial å ena sidan om betydelsen av de optimala proportionerna i organismens katjonkomplettering och å andra sidan om den disproportionerliga sammansättningen '_~1 448 145 av den nutida födan som en påfrestning, som kraftigt bi- drar till hjärt- och kärlsjukdomar. Det bör sålunda anses vara av största vikt att utveckla reformer, som är in- riktade pà en optimering av födan och övriga katjon- källor.Thus, one has access to convincing scientific evidence on the one hand about the importance of the optimal proportions in the cation supplementation of the organism and on the other hand about the disproportionate composition of modern food as a strain which greatly contributes to cardiovascular disease. and vascular diseases. It should thus be considered of the utmost importance to develop reforms that focus on the optimization of food and other cation sources.
Ett idealiskt balanserat preparat belastar inte dis- proportionerligt elektrolytsystemet vare sig det används skilt för sig eller som en del av födan. Som en del av' en disproportionerlig föda minskar denna produkt den rådande disproportionen. Om man vid framställningen eller mineraliseringen av produkten tvingas att nöja sig med en delvis korrigering av den existerande disproportioner- liga halten, kan likväl den belastning som elektrolyt- systemet utsätts för minskas med avseende på korri- geringen, vare sig produkten används allena eller i kombi- nation antingen som en del av en engångsdos eller av den genomsnittliga födan. Om à ena sidan en oralt intagbar produkt är över- eller underbalanserad beträffande en eller flera katjoner, erbjuder den en möjlighet till korrigering av motsatta disproportioner i födan.An ideally balanced preparation does not disproportionately strain the electrolyte system, whether it is used separately or as part of the food. As part of a disproportionate diet, this product reduces the prevailing disproportion. If the production or mineralization of the product is forced to make do with a partial correction of the existing disproportionate content, the load to which the electrolyte system is subjected can nevertheless be reduced with regard to the correction, whether the product is used alone or in combination. nation either as part of a single dose or of the average food. On the one hand, if an orally ingested product is overbalanced or underbalanced with respect to one or more cations, it offers an opportunity to correct opposite disproportions in the diet.
Trots detta har tills vidare inga allmänna åtgärder för optimering av tillgången på elektrolyter vidtagits inom den normala nutritionen. Från terapin av hjärtsjukdomar emanerar några begränsade försök att eliminera en alltför stor natriumbelastning genom att ersätta en del av salt- behovet i dieten, vanligast med kalium- eller ammonium- haltiga substituter.Despite this, so far no general measures have been taken to optimize the supply of electrolytes in normal nutrition. From the therapy of heart disease emanates some limited attempts to eliminate an excessive sodium load by replacing part of the salt requirement in the diet, most often with potassium- or ammonium-containing substitutes.
Likaledes har kaliumtabletter använts för ersättning av kalíumförlusten, som förorsakas av vissa vid behandling av hypertoni använda läkemedel (tiazider).Potassium tablets have also been used to compensate for the loss of potassium caused by certain medicines used to treat hypertension (thiazides).
Karakteristiskt för de använda metoderna är likväl att de ägnar sin uppmärksamhet åt kompenseringen av en enda viss 448 145 katjon. I den moderna industrialiserade världen är lik- väl natrium-, kalium-, magnesium- och kalciumhalterna'i en frisk persons föda disproportionerliga i förhållande till varandra. Kvantitativt överskrider natrium och kalcium avsevärt rekommendationerna i den dagliga dieten, medan kalium- och magnesiummängderna förblir mindre än rekommenderat. Av denna anledning är det skäl att fästa speciell uppmärksamhet på elektrolytbalansen och mineral- mängderna i den dagliga födan.Characteristic of the methods used is nevertheless that they pay attention to the compensation of a single certain 448 145 cation. In the modern industrialized world, however, the sodium, potassium, magnesium and calcium levels in a healthy person's food are disproportionate to each other. Quantitatively, sodium and calcium significantly exceed the recommendations in the daily diet, while the amounts of potassium and magnesium remain less than recommended. For this reason, it is advisable to pay special attention to the electrolyte balance and the amounts of minerals in the daily diet.
Natrium har egenskapen att öka avsöndringen av kalium i njurarna och sålunda att öka förlusten av kalium ur orga- nismen. Normalt borde födan innehålla natrium och kalium i det optimala molförhällandet av Na:K = 1:1.Sodium has the property of increasing the excretion of potassium in the kidneys and thus increasing the loss of potassium from the organism. Normally the food should contain sodium and potassium in the optimal molar ratio of Na: K = 1: 1.
Om födan inte innehåller magnesium i tillräcklig mängd, minskar magnesiumförråden i organismen och likaledes i ovannämnda proportion även kaliumförråden i organismen. Även om den dagliga födan skulle innehålla kalium i riklig mängd, kan organismen inte tillgodogöra sig det, utan kaliumet avgår snabbt ur organismen till följd av brist på magnesium. Den intracellulära elektrolytbalansen för- utsätter ett visst molförhållande mellan magnesium och kalium - optimalt Mg:K = 1:4.If the food does not contain enough magnesium, the magnesium stores in the organism and also in the above-mentioned proportion also the potassium stores in the organism. Even if the daily diet would contain abundant potassium, the organism cannot assimilate it, but the potassium is rapidly excreted from the organism due to lack of magnesium. The intracellular electrolyte balance assumes a certain molar ratio between magnesium and potassium - optimally Mg: K = 1: 4.
Om födan innehåller kalcium i riklig mängd och magnesium i ringa mängd, minskar den stora kalciummängden väsent- ligt absorptionen av magnesium. Detta innebär att med minskande tillgång på magnesium försvåras även det bio- logiska utnyttjandet av kalium. Optimalt borde födan inne- hålla kalcium och magnesium i molförhállandet Ca:Mg = = 1:1 - 2:1. Ändamålet med föreliggande uppfinning är att tillhanda- hålla ett fysiologiskt optimerat mineralvatten, som bidrar till att upprätthålla korrekt katjonbalans i människo- 448 145 kroppen.If the food contains a large amount of calcium and a small amount of magnesium, the large amount of calcium significantly reduces the absorption of magnesium. This means that with declining availability of magnesium, the biological utilization of potassium is also made more difficult. Optimally, the food should contain calcium and magnesium in the molar ratio Ca: Mg = = 1: 1 - 2: 1. The object of the present invention is to provide a physiologically optimized mineral water, which helps to maintain the correct cation balance in the human body.
Mineralvattnet enligt uppfinningen kännetecknas av att det innehåller natrium-, kalium-, magnesium- och eventuellt kalciumjoner i följande koncentrationer: Na = 2 - 40 mmol/liter K = 2 - 40 mmol/liter Mg = 0,66 - 13,3 mmol/liter, och eventuellt Ca = 1,25 - 20 mmol/liter, varvid molförhállandet Na:K uppqår till 1:1.The mineral water according to the invention is characterized in that it contains sodium, potassium, magnesium and possibly calcium ions in the following concentrations: Na = 2 - 40 mmol / liter K = 2 - 40 mmol / liter Mg = 0.66 - 13.3 mmol / liters, and possibly Ca = 1.25 - 20 mmol / liter, the molar ratio Na: K being 1: 1.
Enligt en utföringsform av uppfinningen uppgår mol- förhållandet K:Mg till 3:1 - 4:1 och molförhållandet Ca:Mg, om Ca ingår i mineralvattnet, till 1:1 - 2:1.According to an embodiment of the invention, the molar ratio K: Mg amounts to 3: 1 - 4: 1 and the molar ratio Ca: Mg, if Ca is included in the mineral water, to 1: 1 - 2: 1.
Enligt en specifik utföringsform av uppfinningen är katjon- innehållet i mineralvattnet Na = 16 mmol/liter K = 16 mmol/liter Mg = 4 mmol/liter, och eventuellt Ca = 4 - 8 mmol/liter.According to a specific embodiment of the invention, the cation content of the mineral water is Na = 16 mmol / liter K = 16 mmol / liter Mg = 4 mmol / liter, and optionally Ca = 4-8 mmol / liter.
Claims (3)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI780627A FI60107C (en) | 1978-02-24 | 1978-02-24 | SOM KRYDDA ELLER SOM KONSERVERINGSMEDEL FOER LIVSMEDEL ANVAENDBAR BORDSSALTPRODUKT |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| SE8403228L SE8403228L (en) | 1984-06-14 |
| SE8403228D0 SE8403228D0 (en) | 1984-06-15 |
| SE448145B true SE448145B (en) | 1987-01-26 |
Family
ID=8511503
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7901586A SE440019B (en) | 1978-02-24 | 1979-02-22 | COXAL PRODUCT CONTAINING SODIUM CHLORIDE AND PHYSIOLOGICALLY PREPARABLE POTASSIUM AND MAGNESIUM COMPOUNDS |
| SE8403228A SE448145B (en) | 1978-02-24 | 1984-06-14 | MINERAL WATER WITH PHYSIOLOGICALLY OPTIMIZED CATION COMPOSITION |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7901586A SE440019B (en) | 1978-02-24 | 1979-02-22 | COXAL PRODUCT CONTAINING SODIUM CHLORIDE AND PHYSIOLOGICALLY PREPARABLE POTASSIUM AND MAGNESIUM COMPOUNDS |
Country Status (19)
| Country | Link |
|---|---|
| JP (1) | JPS54126778A (en) |
| AT (1) | AT379294B (en) |
| AU (1) | AU529716B2 (en) |
| BE (1) | BE874413A (en) |
| BR (1) | BR7901216A (en) |
| CA (1) | CA1112173A (en) |
| CH (1) | CH642827A5 (en) |
| DE (1) | DE2906697A1 (en) |
| DK (1) | DK150697C (en) |
| FI (1) | FI60107C (en) |
| FR (1) | FR2450568B1 (en) |
| GB (1) | GB2015863B (en) |
| IN (1) | IN149964B (en) |
| IT (1) | IT1119908B (en) |
| NL (1) | NL7901469A (en) |
| NO (1) | NO150704C (en) |
| SE (2) | SE440019B (en) |
| SU (1) | SU1079166A3 (en) |
| ZA (1) | ZA79796B (en) |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5779860A (en) * | 1980-11-07 | 1982-05-19 | Shogo Yamada | Seasoning composition |
| JPS57159452A (en) * | 1981-03-09 | 1982-10-01 | Japan Organo Co Ltd | Preparation of food made of wheat flour |
| JPS57163468A (en) * | 1981-03-30 | 1982-10-07 | Takeda Chem Ind Ltd | Preparation of salted fish egg |
| US4473595A (en) * | 1982-01-04 | 1984-09-25 | Rood Robert P | Low-sodium salt substitute |
| CH634203A5 (en) * | 1982-01-12 | 1983-01-31 | Haigis Erich Mathias | DRINK FOR PEOPLE AND ANIMALS. |
| CA1245097A (en) * | 1982-11-30 | 1988-11-22 | Lawrence Buckholz, Jr. | Mixed seasoning |
| JPS59198953A (en) * | 1983-04-26 | 1984-11-10 | Kobayashi Seiyaku Kk | Low-sodium salty taste seasoning |
| FR2552631B1 (en) * | 1983-10-03 | 1990-10-19 | Meram Sa Laboratoires | MILK AND MILK PRODUCTS DEPLETED OR NOT IN CALCIUM AND ENRICHED IN MAGNESIUM |
| CH644737A5 (en) * | 1983-10-10 | 1984-08-31 | Baltensperger E Natrex Diaetet | DRINK WITH A HIGH MAGNESIUM CONTENT. |
| FI834309A (en) * | 1983-11-24 | 1985-05-25 | Pharmaconsult Oy | SALTBLANDNING. |
| JPS60175193U (en) * | 1984-04-28 | 1985-11-20 | 東陶機器株式会社 | unit shower room |
| FR2574629B1 (en) * | 1984-12-18 | 1987-04-24 | Curtat Gilbert | PROCESS FOR PRODUCING HYPOSODE CHEESE, ESPECIALLY HYPOSODE GRUYERE CHEESE |
| JPH0321570Y2 (en) * | 1985-03-09 | 1991-05-10 | ||
| JPH0321571Y2 (en) * | 1985-03-20 | 1991-05-10 | ||
| WO1986005954A1 (en) * | 1985-04-09 | 1986-10-23 | Sunpol Consult Aps | Mineral salt preparation and method of producing same |
| JPS6283847A (en) * | 1985-10-07 | 1987-04-17 | Tanpei Seiyaku Kk | Healthy tea |
| EP0291578A1 (en) * | 1987-05-20 | 1988-11-23 | Kopalnia Soli "Wieliczka" | Table salt enriched in bioelements |
| JPS63195062U (en) * | 1987-06-04 | 1988-12-15 | ||
| JPH0523717Y2 (en) * | 1987-11-09 | 1993-06-17 | ||
| JPS6413981A (en) * | 1988-03-01 | 1989-01-18 | Isao Moriya | Method for sterilization and disinfection utilizing magnesium chloride |
| SE465669B (en) * | 1988-07-15 | 1991-10-14 | Hanson & Moehring Ab | SALT FOR FOOD SUMMARY AND PROCEDURE FOR ITS PREPARATION |
| JPH02200164A (en) * | 1989-01-30 | 1990-08-08 | Nikken Food Honsha Kk | Mineral balanced salt and production thereof |
| FR2648318B1 (en) * | 1989-06-20 | 1992-06-19 | Agronomique Inst Nat Rech | HYPOSODE CHEESES AND THEIR PROCESS FOR OBTAINING |
| NL9000613A (en) * | 1990-03-16 | 1991-10-16 | Friesland Condensfab | CALCIUM ENRICHED FERMENTED MILK BEVERAGES. |
| JPH04126049A (en) * | 1990-09-17 | 1992-04-27 | Nichii Suishiyou Kouren:Kk | Mineral-containing low-sodium soy sauce |
| DE4320853C2 (en) * | 1993-06-23 | 1996-06-27 | Kbi Kunststoffbeutel Produktio | Solid mixture of minerals |
| FR2708178B1 (en) * | 1993-07-26 | 1995-10-20 | Midi Salines Est Cie Salins | Composition for salting and preserving foodstuffs and its use. |
| WO1996029890A1 (en) * | 1995-03-24 | 1996-10-03 | Felbena Ag | Preparations for raising the mineral content of water and drinks, a process for producing such preparations and the use of such preparations |
| US5871803A (en) * | 1997-05-30 | 1999-02-16 | Campbell Soup Company | Salt flavor enhancing compositions, food products including such compositions, and methods for preparing such products |
| US6541050B1 (en) | 1998-11-27 | 2003-04-01 | Campbell Soup Company | Salt flavor enhancing compositions, food products including such compositions, and methods for preparing such products |
| FR2811518B1 (en) * | 2001-05-11 | 2003-02-14 | Olivier Claude Alain Roujansky | DECREASE IN ACIDITY AND MAGNESIUM ENRICHMENT OF SPECIAL DAIRY FOOD COMPOSITIONS PREVIOUSLY ACIDIFIED BY LACTOFERMENTATION OR BY ADDITION OF LACTIC ACID |
| NL1019544C2 (en) | 2001-12-12 | 2003-06-13 | Sara Lee De Nv | Device for offering and dispensing mineral water suitable for consumption. |
| KR20090004886A (en) * | 2006-02-28 | 2009-01-12 | 데이빗 알. 비먼 | Water formulation |
| CA2662951A1 (en) | 2006-09-04 | 2008-03-13 | Barry Callebaut Ag | Method for preparing chocolates and/or chocolate-/cocoa-flavoured compositions |
| US20100227023A1 (en) | 2009-03-06 | 2010-09-09 | Danisco A/S | Seasoning blend |
| FI20105209A0 (en) | 2010-03-04 | 2010-03-04 | Ekakos Oy | Products and Method |
| FI128196B (en) | 2013-06-10 | 2019-12-13 | Valio Oy | Cheese and method for its manufacturing |
| DE102017200434A1 (en) * | 2016-01-13 | 2017-07-13 | Robert Finke | Whey-containing body care product |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1998179A (en) * | 1930-12-27 | 1935-04-16 | Wolf Eduard Julius | Physiologically balanced salt mixture |
| GB388513A (en) * | 1930-12-27 | 1933-03-02 | Nordmark Werke Gmbh | Improvements in and relating to the treatment of organic materials of cellular character with salt solutions and salt mixtures for use in such treatment |
| DK50773C (en) * | 1934-02-13 | 1935-10-14 | Richard Gottschalk | Freewheel Hub with Retirement Brake. |
| US2224252A (en) * | 1938-10-10 | 1940-12-10 | Edward C Callaway | Food product and the process of making it |
| DK78665C (en) * | 1949-06-30 | 1954-12-27 | Cand Agr Et Forest | Process for the preparation of a nutrient salt solution. |
| DK100573C (en) * | 1953-08-03 | 1964-12-14 | Mond Nickel Co Ltd | A method of introducing a solid additive into a metal melt, and an apparatus for carrying out the method. |
| US3514296A (en) * | 1967-01-16 | 1970-05-26 | Morton Int Inc | Salt substitute |
| FR1583412A (en) * | 1967-12-20 | 1969-10-31 | ||
| FR2082097A5 (en) * | 1970-03-03 | 1971-12-10 | Abeille Elzear | Evaporated sea water - use in food as a source of trace elements |
| DE2060601B2 (en) * | 1970-09-02 | 1980-05-22 | V. Berthelsen Industrial Commercial Co. A/S, Hellerup (Daenemark) | Food supplements |
| ZA73288B (en) * | 1972-02-25 | 1973-10-31 | Hoffmann La Roche | Mineral salts containing preparation |
| GB1493993A (en) * | 1975-05-16 | 1977-12-07 | Howard A | Dietary supplement and dietary methods employing said supplement for the treatment of obesity |
| DE2527003A1 (en) * | 1974-06-25 | 1976-01-15 | Chimicasa Gmbh | DIET SALT |
| GB1422193A (en) * | 1974-07-26 | 1976-01-21 | Smith Kline French Lab | Pharmaceutical compositions |
| US4068006A (en) * | 1976-10-07 | 1978-01-10 | Akzona Incorporated | Salt seasoning mixture |
-
1978
- 1978-02-24 FI FI780627A patent/FI60107C/en not_active IP Right Cessation
-
1979
- 1979-02-20 AU AU44402/79A patent/AU529716B2/en not_active Ceased
- 1979-02-20 ZA ZA79796A patent/ZA79796B/en unknown
- 1979-02-20 DK DK073779AA patent/DK150697C/en active
- 1979-02-21 DE DE19792906697 patent/DE2906697A1/en not_active Withdrawn
- 1979-02-21 CA CA322,056A patent/CA1112173A/en not_active Expired
- 1979-02-22 SE SE7901586A patent/SE440019B/en not_active IP Right Cessation
- 1979-02-23 SU SU792733600A patent/SU1079166A3/en active
- 1979-02-23 CH CH182079A patent/CH642827A5/en unknown
- 1979-02-23 FR FR7904742A patent/FR2450568B1/en not_active Expired
- 1979-02-23 GB GB7906494A patent/GB2015863B/en not_active Expired
- 1979-02-23 BR BR7901216A patent/BR7901216A/en unknown
- 1979-02-23 BE BE193665A patent/BE874413A/en not_active IP Right Cessation
- 1979-02-23 NO NO790635A patent/NO150704C/en unknown
- 1979-02-23 NL NL7901469A patent/NL7901469A/en not_active Application Discontinuation
- 1979-02-23 JP JP2059679A patent/JPS54126778A/en active Granted
- 1979-02-23 AT AT0144179A patent/AT379294B/en not_active IP Right Cessation
- 1979-02-23 IT IT67413/79A patent/IT1119908B/en active
- 1979-02-24 IN IN170/CAL/79A patent/IN149964B/en unknown
-
1984
- 1984-06-14 SE SE8403228A patent/SE448145B/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| DK73779A (en) | 1979-08-25 |
| GB2015863A (en) | 1979-09-19 |
| CA1112173A (en) | 1981-11-10 |
| ZA79796B (en) | 1980-02-27 |
| GB2015863B (en) | 1982-12-15 |
| BR7901216A (en) | 1979-10-02 |
| SE8403228L (en) | 1984-06-14 |
| IT1119908B (en) | 1986-03-19 |
| FR2450568A1 (en) | 1980-10-03 |
| ATA144179A (en) | 1985-05-15 |
| NO150704C (en) | 1984-12-05 |
| FI60107B (en) | 1981-08-31 |
| FI780627A (en) | 1979-08-25 |
| SE8403228D0 (en) | 1984-06-15 |
| DE2906697A1 (en) | 1979-09-06 |
| SU1079166A3 (en) | 1984-03-07 |
| IT7967413A0 (en) | 1979-02-23 |
| JPS5756858B2 (en) | 1982-12-01 |
| CH642827A5 (en) | 1984-05-15 |
| NL7901469A (en) | 1979-08-28 |
| AT379294B (en) | 1985-12-10 |
| JPS54126778A (en) | 1979-10-02 |
| BE874413A (en) | 1979-06-18 |
| AU529716B2 (en) | 1983-06-16 |
| IN149964B (en) | 1982-06-19 |
| SE440019B (en) | 1985-07-15 |
| NO150704B (en) | 1984-08-27 |
| SE7901586L (en) | 1979-08-25 |
| DK150697B (en) | 1987-06-01 |
| AU4440279A (en) | 1979-08-30 |
| FI60107C (en) | 1982-12-13 |
| NO790635L (en) | 1979-08-27 |
| DK150697C (en) | 1991-11-25 |
| FR2450568B1 (en) | 1987-05-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE448145B (en) | MINERAL WATER WITH PHYSIOLOGICALLY OPTIMIZED CATION COMPOSITION | |
| Nesheim et al. | Interrelationships between dietary levels of sodium, chlorine and potassium | |
| Lewin et al. | Iatrogenic rickets in low-birth-weight infants | |
| McGill Jr et al. | The influence of alloxan diabetes on cholesterol atheromatosis in the rabbit. | |
| ES2546055T3 (en) | Nutritional supplements for individuals 50 years or older to improve vitality, immunity, eye and bone health | |
| US4784852A (en) | Composition for human supply of selenium as trace element | |
| Merlis | Diamox: a carbonic anhydrase inhibitor: its use in epilepsy | |
| CA2256133A1 (en) | Drinking fluid | |
| Chandler | Pet food safety: sodium in pet foods | |
| EP0221096B1 (en) | Mineral salt preparation and method of producing same | |
| Smith et al. | The early weaning of pigs: I. The effect upon growth of variations in the protein, fat, sucrose, antibiotic, vitamin and mineral contents of diets for pigs of 8–25 lb. live weight and a comparison of wet and dry feeding | |
| Hawks et al. | The interrelationship of calcium, phosphorus and nitrogen in the metabolism of pre-school children | |
| US5035888A (en) | Therapeutically useful mineral composition | |
| Cowell | The excretion of calcium by the large intestine of the rabbit | |
| Relman et al. | The acidifying effect of rubidium in normal and potassium-deficient alkalotic rats | |
| RU2159112C1 (en) | Method of normalizing metabolic processes in cattle | |
| Sure et al. | The specific effect of vitamin B on growth | |
| M Abo-El-Saad et al. | Nutritional and Medicinal Value of Mineral Elements in Dates | |
| RU2650640C1 (en) | Energometabolic composition for the prevention and treatment of rumen acidosis, metabolic acidosis in neonatal cows | |
| NO158773B (en) | MINERAL WATER. | |
| JPH08205819A (en) | Beverage for health | |
| JPH10203989A (en) | Emotional disturbance improver | |
| CN109418804A (en) | A kind of seaweed chewable tablets and preparation method thereof | |
| Topliff | Electrolytes, cations, and anions in the performance horse | |
| DE102005039542A1 (en) | Health/vitalizing drink combination, useful for hydrotherapeutic improvement of the body's cellular metabolism, comprises diluted iodized brine as water, natural apple juice, natural bio materials as additives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NAV | Patent application has lapsed |
Ref document number: 8403228-3 |